The effect of combined administration of ethanol and gabapentin on rabbit electroencephalographic activity

Basic and Clinical Pharmacology and Toxicology

Volumn 99, Issue 5, 2006, Pages 383-390

  Pietrzak, Bogusława ^a   Czarnecka, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; GABAPENTIN;

ANIMAL EXPERIMENT; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT;

AMINES; ANIMALS; ANTICONVULSANTS; BRAIN; CENTRAL NERVOUS SYSTEM DEPRESSANTS; CYCLOHEXANECARBOXYLIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROENCEPHALOGRAPHY; ETHANOL; FEMALE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 33750561905     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2006.pto_518.x     Document Type: Article

References (38)

1. Ariwodola, O. J. & J. L. Weiner: Ethanol potentiation of GABAergic synaptic transmission may be self-limiting: role of presynaptic GABA(B) receptors. J. Neurosci. 2004, 24, 10679-10686.
2. Bertrand, S., G. Y. Ng, M. G. Purisai, S. E. Wolfe, M. W. Severidt, D. Nouel, R. Robitaille, M. J. Low, G. P. O'Neill, K. Metters, J. C. Lacaille, B. M. Chronwall & S. J. Morris: The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma-aminobutyric acid type B receptors negatively coupled to voltage-dependent calcium channels. J. Pharmacol. Exp. Ther. 2001, 298, 15-24.
3. Besheer, J., V. Lepoutre & C.W. Hodge: GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6L mice. Psychopharmacology (Berl), 2004, 174, 358-366.
4. Bonnet, U., M. Banger, F. M. Leweke, M. Maschke, T. Kowalski & M. Gastpar: Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry 1999, 32, 107-109.
5. Bozikas, V., P. Petrikis, K. Gamvrula, I. Savvidou & A. Karavatos: Treatment of alcohol withdrawal with gabapentin. Prog. Neuropsychopharmacol. Biol. Psychiatry 2002, 26, 197-199.
6. Cott, J., A. Carlsson, J. Engel & M. Lindqwist: Suppression of ethanol-induced locomotor stimulation by GABA-like drugs. Arch. Pharmacol. 1976, 295, 203-209.
7. Crews, F. T., A. L. Morrow, H. Criswell & G. Breese: Effects of ethanol on ion channels. Int. Rev. Neurobiol. 1996, 39, 283-367.
8. Czarnecka, E. B. Pietkiewicz & J. Skrȩtkowicz: Investigations of central interaction of ethanol and clonidine. Pol. J. Pharmacol. Pharm. 1986, 38, 157-166.
9. 2δ subunit of calcium channel. J. Biol. Chem. 1996, 271, 5768-5776.
10. Gu, Y. & L. Y. Huang: Gabapentin potentiates N-methyl-D-aspartate receptor mediated currents in rat GABAergic dorsal horn neurons. Neurosci. Lett. 2002, 324, 177-180.
11. Hundt, W., W. Danysz, S. M. Holter & R. Spanagel: Ethanol and N-methyl-D-aspartate receptor complex interactions: a detailed drug discrimination study in the rat. Psychopharmacology (Berl) 1998, 135, 44-51.
12. La Roche, S. M. & S. L. Helmers: The new antiepileptic drugs: scientific review. J. Amer. Med. Ass. 2004, 291, 605-614.
13. Li, S. P., J. H. Kim, M. S. Park, J. Y. Bahk, B. C. Chung & M. O. Kim: Ethanol modulates the expression of GABA(B) receptor mRNAs in the prenatal rat brain in an age and area dependent manner. Neuroscience 2005a, 134, 857-866.
14. Li, S. P., M. S. Park, G. Z. Jin, J. H. Kim, H. L. Lee, Y. L. Lee, J. Y. Bahk, T. J. Park, P. O. Koh, B. C. Chung & M. O. Kim: Ethanol modulates GABA(B) receptor expression in cortex and hippocampus of the adult rat brain. Brain Res. 2005b, 1061, 27-35.
15. Liang, J. H., F. Chen, E. Krstew, M. S. Cowen, F. Y. Carroll, D. Crawford, P. M. Beart & A. J. Lawrence: The GABA(B) receptor allosteric modulator CGP7930, like baclofen, reduces operant self-administration of ethanol in alcohol-preferring rats. Neuropharmacology 2006, 50, 632-639.
16. Littleton, J. M., D. Lovinger, S. Liljequist, R. Ticku, I. Matsumoto & S. Barron: Role of polyamines and NMDA receptors in ethanol dependence and withdrawal. Alcohol Clin. Exp. Res. 2001, 25, Suppl 5, 132-136.
17. Loscher, W., D. Honack & C. P. Taylor: Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci. Lett. 1991, 128, 150-154.
18. Malcolm, R., H. Myrick, K. T. Brady & J. C. Ballenger: Update on anticonvulsants for the treatment of alcohol withdrawal. Am. J. Addict. 2001, 10 Suppl, 16-23.
19. Ng, G. Y., S. Bertrand, R. Sullivan, N. Ethier, J. Wang, J. Yergey, M. Belley, L. Trimble, K. Bateman, L. Alder, A. Smith, R. McKernan, K. Metters, G. P. O'Neill, J. C. Lacaille & T. E. Hebert: Gamma-aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action. Mol. Pharmacol 2001, 59, 144-152.
20. Pietrzak, B. & E. Czarnecka: Effect of the combined administration of ethanol and acamprosate on rabbit EEG. Pharmacol. Rep. 2005, 57, 61-69.
21. Pietrzak, B. & E. Czarnecka: The effect of combined administration of ethanol and sertraline, fluoxetine and citalopram on rabbit EEG. Pharmacol. Res. 2003, 47, 527-534.
22. Pietrzak, B. & E. Kubik-Bogucka: Influence of mianserin on some central effects of ethanol. Pharmacol. Res. 2002, 46, 47-54.
23. Pohorecky, L. A. & J. Brick: Pharmacology of ethanol. Pharmacol. Ther. 1988, 36, 335-427.
24. Rekling, J. C.: Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci. Lett. 2003, 335, 167-170.
25. Salinsky, M. C., L. M. Binder, B. S. Oken, D. Storzbach, C. R. Aron, C. B. Dodrill: Effects of gabapentin and carbamazepine on the EEG and cognition in healthy volunteers. Epilepsia 2002, 43, 482-490.
26. Sarantopoulos, C., B. McCallum, D. Sapunar, W. M. Kwok & Q. Hogan: ATP-sensitive potassium channels in rat primary afferent neurons: the effect of neuropathic injury and gabapentin. Neurosci. Lett. 2003, 343, 185-189.
27. Sawyer, C. H., J. W. Everett & J. D. Green: The rabbit diencephalon in stereotaxic coordinates. J. Comp. Neurol. 1954, 101, 801-824.
28. Spanagel, R.: The influence of opioid antagonists on the discriminative stimulus effects of ethanol. Pharmacol. Biochem. Behav. 1996, 54, 645-649.
29. Surges, R., T. M. Friedman & T. J. Feuerstein: Gabapentin increases the hyperpolarization-activated cation current Ih in rat CA1 pyramidal cells. Epilepsia 2003, 44, 150-156.
30. Taylor, C. P., N. S. Gee, T. Z. Su, J. D. Kocsis, D. F. Welty, J. P. Brown, D. J. Dooley, P. Boden & L. Singh: A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 1998, 29, 233-249.
31. Tran, K. T., D. Hranicky, T. Lark & N. J. Jacob: Gabapentin withdrawal syndrome in the presence of a taper. Bipolar Disord. 2005, 7, 302-304.
32. Trojnar, M. K., R. Małek, M. Chrościńska, S. Nowak, B. Błaszczyk & S. J. Czuczwar: Neuroprotective effects of antiepileptic drugs. Pol. J. Pharmacol. 2002, 54, 557-566.
33. Vanover, K. E.: Interaction of ethanol with excitatory amino acid receptor antagonists in mice. Eur. J. Pharmacol. 1999, 368, 137-142.
34. Volmer, K., A. Von Hodenberg & E. Kolle: Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Drug Res. 1986, 36, 830-839.
35. Voris, J., N. L. Smith, S. M. Rao, D. L. Thorne & Q. J. Flowers: Gabapentin for the treatment of ethanol withdrawal. Subst. Abus. 2003, 24, 129-132.
36. Watson, W. P., E. Robinson & H. J. Little: The novel anticonvulsant, gabapentin, protects against both convulsant and anxiogenic aspects of the ethanol withdrawal syndrome. Neuropharmacology 1997, 36, 1369-1375.
37. Wong, I. C. & S. D. Lhatoo: Adverse reactions to new anticonvulsant drugs. Drug Saf. 2000, 23, 35-56.
38. Yoon, M. H., H. B. Bae & J. I. Choi: Antinociceptive interactions between intrthecal gabapentin and MK801 or NBQX in rat formalin test. J. Korean. Med. Sci. 2005, 20, 307-312.